August 1, 2008

Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis (Medical News Today)

NeoStrata announced findings from an ongoing 12-week study that demonstrates benefits of a novel topically applied LCD (coal tar) solution (Psorent(TM)) versus calcipotriol cream (Dovonex(R)) in treatment of moderate plaque psoriasis.

Original post by Epinions Recent Content for Golf

Filed under golf business by

del.icio.us Digg Furl Reddit Ask Google Newsvine Slashdot Spurl Tailrank Technorati Windows Live Yahoo! Help

Permalink • Print • Comment

Trackback uri

http://www.strictlysports.com/golf_product_news/2008/08/01/study-reveals-novel-lcd-solution-provides-significant-benefits-versus-calcipotriol-in-treatment-of-moderate-psoriasis-medical-news-today/trackback/

Leave a comment

You must be logged in to post a comment.



Related Posts
  • Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis (PR Newswire via Yahoo! Finance)
  • Findings From Landmark Study Show Ustekinumab Demonstrated Superior Efficacy To Enbrel(R) (Etanercept) In Treatment Of … (Medical News Today)
  • Abbott’s HUMIRA® (adalimumab) Receives FDA Approval For Moderate To Severe Chronic Plaque Psoriasis (Medical News Today)
  • Findings From Landmark Study Show Ustekinumab Demonstrated Superior Efficacy to Enbrel(R) (Etanercept) in Treatment of … (PR Newswire via Yahoo! Finance)
  • New Evidence Advocates The Use Of Enbrel To Combat And Effectively Control The Debilitating Symptoms Of Psoriasis (Medical News Today)
    • Consultative Citizen Participation (Dialogue) | Have Love Will Blog | Collaborative-Wisdom | Willa For Wedding (Manitoba) | Fundraising-Best Practises and News
    Made with WordPress and a search engine optimized WordPress theme • Digital Moon skin by Denis de Bernardy